Current position:Home >Product >
7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-3-(2-oxo-2-phenylethylidene)-4,5-diphenyl-
7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-3-(2-oxo-2-phenylethylidene)-4,5-diphenyl-(61317-39-3)
- Name: 7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-3-(2-oxo-2-phenylethylidene)-4,5-diphenyl-
- Synonyms:
- Molecular Formula:C24H17NO2S2
- Molecular Weight:415.536
- CAS Registry Number:61317-39-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.61317-39-3 7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-3-(2-oxo-2-phenylethylidene)-4,5-diphenyl-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 61317-06-4/Acetamide, N-[[4-[[(4-bromophenyl)(4-methoxyphenyl)-1-(4-methylphenyl)-1H-pyraz ol-4-yl]azo]phenyl]sulfonyl]-
- 61317-07-5/Benzenesulfonamide, 4-[[(4-bromophenyl)(4-methoxyphenyl)-1-(4-methylphenyl)-1H-pyrazol-4- yl]azo]-N-(4-chlorophenyl)-
- 61317-08-6/Benzenesulfonamide, 4-[[(4-bromophenyl)(4-methoxyphenyl)-1-(4-methylphenyl)-1H-pyrazol-4- yl]azo]-N-(4-methoxyphenyl)-
- 61317-09-7/Benzenesulfonamide, 4-[[(4-bromophenyl)(4-methoxyphenyl)-1-(4-methylphenyl)-1H-pyrazol-4- yl]azo]-N-(4-methylphenyl)-
- 61317-18-8/1,2-Ethanediol, bis(hydrogen carbonate), dipotassium salt
- 61317-20-2/Morpholine, 4-[3-(2,2-diphenylhydrazino)propyl]-, ethanedioate (1:1)
- 61317-22-4/Pyrrolidine, 1-[2-(2,2-diphenylhydrazino)ethyl]-, ethanedioate (1:1)
- 61317-25-7/Benzene, 1,2,4,5-tetramethyl-3,6-bis[(2,4,6-tribromophenoxy)methyl]-
- 61317-26-8/2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)cyclohexyl]-4-piperidinyl]-1,3-dihydro-
- 61317-27-9/1H-Indazol-3-amine, 5-chloro-N,N-dimethyl-
- 61317-28-0/2-Thiophenecarboxaldehyde, 5-bromo-, 2-benzothiazolylhydrazone
- 61317-30-4/Benzenamine, N-[3,5-dimethyl-1-(2-methylpropyl)-2-hexenylidene]-4-methoxy-
- 61317-31-5/Acetamide, N-(4-methoxy-9-acridinyl)-N-methyl-
- 61317-32-6/5-Amino-2(1H)-quinolinone
- 61317-33-7/2,5(1H,6H)-Quinolinedione, 7,8-dihydro-, 5-oxime
- 61317-35-9/Phosphoric acid, monoethyl ester, barium salt
- 61317-36-0/Morpholine, 4-[2-(9H-carbazol-2-yl)-1-thioxoethyl]-
- 61317-37-1/7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-4-(2-methoxyphenyl)-5-methyl-3-(2-oxopropylidene)-
- 61317-38-2/7H-1,2,4-Dithiazepin-7-one, 4-(4-chlorophenyl)-3,4-dihydro-5-methyl-3-(2-oxopropylidene)-
- 61317-39-3/7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-3-(2-oxo-2-phenylethylidene)-4,5-diphenyl-
- 61317-40-6/7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-4-(4-methylphenyl)-3-(2-oxo-2-phenylethylidene)-5-phenyl-
- 61317-41-7/7H-1,2,4-Dithiazepin-7-one, 3,4-dihydro-4-(2-methoxyphenyl)-3-(2-oxo-2-phenylethylidene)-5-phenyl -
- 61317-42-8/7H-1,2,4-Dithiazepin-7-one, 4-(4-chlorophenyl)-3,4-dihydro-3-(2-oxo-2-phenylethylidene)-5-phenyl-
- 61317-43-9/Butanethioamide, N-(2-methoxyphenyl)-3-oxo-
- 61317-44-0/Benzenepropanethioamide, N-(4-methylphenyl)-b-oxo-
- 61317-45-1/Benzenepropanethioamide, N-(2-methoxyphenyl)-b-oxo-
- 61317-46-2/Benzenepropanethioamide, N-(4-chlorophenyl)-b-oxo-
- 61317-48-4/3H-Pyrazolo[4,3-f]quinoline, 3-acetyl-
- 61317-49-5/2H-Pyrazolo[4,3-f]quinoline, 2-acetyl-
- 61317-50-8/1H-Pyrazolo[3,4-f]quinoline, 1-acetyl-